KR101868834B1 - 폴리에틸렌 글리콜 및 전해질을 포함하는 용액 - Google Patents

폴리에틸렌 글리콜 및 전해질을 포함하는 용액 Download PDF

Info

Publication number
KR101868834B1
KR101868834B1 KR1020127005284A KR20127005284A KR101868834B1 KR 101868834 B1 KR101868834 B1 KR 101868834B1 KR 1020127005284 A KR1020127005284 A KR 1020127005284A KR 20127005284 A KR20127005284 A KR 20127005284A KR 101868834 B1 KR101868834 B1 KR 101868834B1
Authority
KR
South Korea
Prior art keywords
solution
aqueous solution
sweetener
peg
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020127005284A
Other languages
English (en)
Korean (ko)
Other versions
KR20120081584A (ko
Inventor
크리스 셀돈
던 패드필드
프란시스 모리세이
Original Assignee
노어긴 비.브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 노어긴 비.브이. filed Critical 노어긴 비.브이.
Publication of KR20120081584A publication Critical patent/KR20120081584A/ko
Application granted granted Critical
Publication of KR101868834B1 publication Critical patent/KR101868834B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
KR1020127005284A 2009-07-30 2010-07-30 폴리에틸렌 글리콜 및 전해질을 포함하는 용액 Active KR101868834B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0913295.2A GB0913295D0 (en) 2009-07-30 2009-07-30 Improvements in and relating to pharmaceutical compositions
GB0913295.2 2009-07-30
PCT/GB2010/001455 WO2011012866A1 (en) 2009-07-30 2010-07-30 Solutions comprising polyethylene glycol and electrolytes

Publications (2)

Publication Number Publication Date
KR20120081584A KR20120081584A (ko) 2012-07-19
KR101868834B1 true KR101868834B1 (ko) 2018-06-19

Family

ID=41067102

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020127005284A Active KR101868834B1 (ko) 2009-07-30 2010-07-30 폴리에틸렌 글리콜 및 전해질을 포함하는 용액

Country Status (32)

Country Link
US (2) US20120135090A1 (https=)
EP (1) EP2459218B1 (https=)
JP (1) JP5708943B2 (https=)
KR (1) KR101868834B1 (https=)
CN (2) CN102548580A (https=)
AR (2) AR077347A1 (https=)
AT (1) AT12341U1 (https=)
AU (1) AU2010277354B2 (https=)
BE (1) BE1019753A5 (https=)
BR (1) BR112012001899B8 (https=)
CA (1) CA2769247C (https=)
CY (1) CY1122081T1 (https=)
DK (1) DK2459218T3 (https=)
EA (1) EA025112B1 (https=)
ES (1) ES2388095B1 (https=)
FR (1) FR2948569B3 (https=)
GB (3) GB0913295D0 (https=)
HR (1) HRP20191465T1 (https=)
HU (1) HUE046705T2 (https=)
IT (1) IT1402374B1 (https=)
LT (1) LT2459218T (https=)
MX (1) MX337114B (https=)
NL (1) NL2005176C2 (https=)
NZ (1) NZ597822A (https=)
PL (1) PL2459218T3 (https=)
PT (1) PT2459218T (https=)
RS (1) RS59294B1 (https=)
SI (1) SI2459218T1 (https=)
SM (1) SMT201900569T1 (https=)
TW (1) TWI478716B (https=)
WO (1) WO2011012866A1 (https=)
ZA (1) ZA201200661B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107260661A (zh) 2011-01-31 2017-10-20 诺金股份有限公司 对组合物的改进和与组合物有关的改进
GB201200637D0 (en) 2012-01-13 2012-02-29 Norgine Bv Improvements in and relating to compositions
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
CN102600201B (zh) * 2012-02-07 2014-07-16 舒泰神（北京）生物制药股份有限公司 用于通便和清肠的药物组合物及其制备方法
US20140065076A1 (en) * 2012-08-30 2014-03-06 Otsuka Pharmaceutical Co. Ltd. Container with concentrated substance and method of using the same
MX382868B (es) 2012-09-11 2025-03-13 Norgine Bv Composiciones que comprenden polietilenglicol y ascorbato.
HUE046754T2 (hu) 2013-03-15 2020-03-30 Braintree Laboratories Inc Kettõs felhasználású orális gyógyszer kompozíció tabletták szulfát sókból és eljárás ezek alkalmazására
CN112494511A (zh) * 2020-12-06 2021-03-16 天津康哲医药科技发展有限公司 一种聚乙二醇钠钾口服药物制剂的制备

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005049049A1 (en) * 2003-11-17 2005-06-02 Braintree Laboratories, Inc. Therapeutic peg solution concentrate
WO2006122104A1 (en) * 2005-05-06 2006-11-16 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0231356A1 (en) * 1985-08-01 1987-08-12 Braintree Laboratories, Inc. Low-sodium laxative and lavage formulation
JP2596764B2 (ja) 1987-11-18 1997-04-02 ルセル森下株式会社 腸管洗浄液剤
US5378470A (en) 1989-07-25 1995-01-03 Henning Berlin Gmbh Rectally administered pharmaceutical preparation
EP0670725A1 (en) 1992-11-24 1995-09-13 Block Drug Company, Inc. Pharmaceutical compositions for use in gastrointestinal washes
RU2111741C1 (ru) * 1994-10-27 1998-05-27 Государственный научный центр колопроктологии Министерства здравоохранения и медицинской промышленности Российской Федерации Вещество для общего промывания желудочно-кишечного тракта
US5710183A (en) 1995-07-14 1998-01-20 Halow; George M. Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent
US6162464A (en) 1997-03-31 2000-12-19 Inkine Pharmaceutical, Inc. Non-aqueous colonic purgative formulations
US6071523A (en) 1998-06-03 2000-06-06 Taro Pharmaceuticals Industries, Ltd. Spill resistant pharmaceutical compositions in semi-solid form
US6048901A (en) 1999-04-20 2000-04-11 Braintree Laboratories, Inc. Method of reducing intestinal gas, cramping and anorectal irritation
IL137275A0 (en) 2000-07-12 2001-07-24 Yosefus Azaria Pharmaceutical composition for the treatment of anal fissures
JP4535234B2 (ja) 2001-10-29 2010-09-01 味の素株式会社 腸管洗浄製剤
US6946149B2 (en) 2002-04-30 2005-09-20 Braintree Laboratories, Inc. Salt solution for colon cleansing
US7291324B2 (en) * 2002-10-22 2007-11-06 Braintree Laboratories Inc. Method of bowel cleansing
GB0224909D0 (en) * 2002-10-25 2002-12-04 Norgine Europe Bv Colon cleansing compositions
US7332184B2 (en) 2003-03-28 2008-02-19 Queen's University At Kingston Colonic cleansing composition and method
US20050152989A1 (en) 2003-07-09 2005-07-14 Braintree Laboratories, Inc. Method for treating irritable bowel syndrome
GB0409104D0 (en) 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
US20070082061A1 (en) * 2005-10-07 2007-04-12 Nelson Ayala Reduction of saltiness with sweeteners
DE102006001199A1 (de) 2006-01-10 2007-07-12 Medicoforum Gmbh Fixe Kombination von Substanzen unter Beigabe von Entschäumern zum Einsatz als Darmspüllösung und/oder Laxans
ES2278537B1 (es) 2006-01-30 2008-09-16 Laboratorios Casen-Fleet, S.L. Procedimiento de fabricacion de una solucion a base de polietilenglicol con electrolitos, producto obtenido y uso.
CN1850112B (zh) * 2006-03-06 2011-06-29 北京圣永制药有限公司 聚乙二醇-电解质口服溶液
DE112008002398A5 (de) 2007-09-22 2010-07-29 Bayer Consumer Care Ag Zusammensetzung mit Wirkstoffkombination aus einem Laxans und einem Entschäumer zur Behandlung von Obstipation
US8362083B2 (en) * 2008-01-15 2013-01-29 C.B. Fleet Company Inc. Taste-masked docusate compositions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005049049A1 (en) * 2003-11-17 2005-06-02 Braintree Laboratories, Inc. Therapeutic peg solution concentrate
WO2006122104A1 (en) * 2005-05-06 2006-11-16 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition

Also Published As

Publication number Publication date
AU2010277354A1 (en) 2012-02-16
CA2769247A1 (en) 2011-02-03
PT2459218T (pt) 2019-09-27
JP5708943B2 (ja) 2015-04-30
NL2005176A (en) 2011-01-31
BR112012001899B1 (pt) 2021-05-04
EP2459218A1 (en) 2012-06-06
ZA201200661B (en) 2012-10-31
GB201012903D0 (en) 2010-09-15
AT12341U1 (de) 2012-04-15
HUE046705T2 (hu) 2020-03-30
JP2013500322A (ja) 2013-01-07
DK2459218T3 (da) 2019-10-21
MX337114B (es) 2016-02-12
ES2388095B1 (es) 2014-02-05
CN103932979B (zh) 2019-06-14
CY1122081T1 (el) 2020-11-25
ES2388095A8 (es) 2013-07-01
LT2459218T (lt) 2019-09-25
EA025112B1 (ru) 2016-11-30
RS59294B1 (sr) 2019-10-31
KR20120081584A (ko) 2012-07-19
AU2010277354B2 (en) 2016-02-11
AR077347A1 (es) 2011-08-17
BR112012001899B8 (pt) 2021-05-25
SI2459218T1 (sl) 2019-10-30
TW201109021A (en) 2011-03-16
GB2472324A (en) 2011-02-02
GB2472324A8 (en) 2011-02-23
HRP20191465T1 (hr) 2019-11-15
US9468686B2 (en) 2016-10-18
GB2478076B (en) 2012-06-06
CN102548580A (zh) 2012-07-04
GB2478076A (en) 2011-08-24
NL2005176C2 (en) 2011-05-17
BE1019753A5 (fr) 2012-12-04
FR2948569A3 (fr) 2011-02-04
FR2948569B3 (fr) 2012-01-13
GB0913295D0 (en) 2009-09-02
TWI478716B (zh) 2015-04-01
US20140147518A1 (en) 2014-05-29
AR117718A2 (es) 2021-08-25
GB2472324C (en) 2012-03-07
GB201108383D0 (en) 2011-06-29
EP2459218B1 (en) 2019-07-17
CN103932979A (zh) 2014-07-23
WO2011012866A1 (en) 2011-02-03
MX2012001108A (es) 2012-06-01
US20120135090A1 (en) 2012-05-31
EA201200220A1 (ru) 2012-06-29
IT1402374B1 (it) 2013-09-04
BR112012001899A2 (pt) 2016-03-15
NZ597822A (en) 2013-08-30
ES2388095A1 (es) 2012-10-08
CA2769247C (en) 2017-10-31
SMT201900569T1 (it) 2019-11-13
HK1150430A1 (en) 2011-12-30
PL2459218T3 (pl) 2020-03-31
GB2472324B (en) 2011-10-05
ITMI20101436A1 (it) 2011-01-31

Similar Documents

Publication Publication Date Title
KR101868834B1 (ko) 폴리에틸렌 글리콜 및 전해질을 포함하는 용액
JP6498250B2 (ja) 組成物の改良及び組成物関連
JP2026009367A (ja) 包装体入り含水組成物
AU2012213180A1 (en) Improvements in and relating to compositions
DE202010016398U1 (de) Verbesserungen bei pharmazeutischen Zusammensetzungen und bezüglich pharmazeutischer Zusammensetzungen
NZ613401B2 (en) Polyethylene Glycol Solutions for Use in the Treatment of Constipation

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

D13-X000 Search requested

St.27 status event code: A-1-2-D10-D13-srh-X000

D14-X000 Search report completed

St.27 status event code: A-1-2-D10-D14-srh-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

X091 Application refused [patent]
T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PX0901 Re-examination

St.27 status event code: A-2-3-E10-E12-rex-PX0901

E90F Notification of reason for final refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PX0701 Decision of registration after re-examination

St.27 status event code: A-3-4-F10-F13-rex-PX0701

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

FPAY Annual fee payment

Payment date: 20210526

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20220427

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8